1-3 of 3
Jen Jen Yeh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to MLN8237 in Pancreatic Cancer Is Not Dependent on RalA Phosphorylation

Nicole F. Neel, Jeran K. Stratford, Vaishali Shinde, Jeffrey A. Ecsedy, Timothy D. Martin, Channing J. Der, Jen Jen Yeh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (1): 122–133.
DOI: https://doi.org/10.1158/1535-7163.MCT-12-1232
Published: 13 January 2014
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract C188: RalA phosphorylation as a biomarker in pancreatic ductal adenocarcinoma for Aurora A kinase inhibition in response to the investigational agent MLN8237.

Nicole F. Neel, Jeffrey A. Escedy, Vaishali Shinde, Channing J. Der, Jen Jen Yeh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C188.
DOI: https://doi.org/10.1158/1535-7163.TARG-11-C188
Published: 12 November 2011
View article
Journal Articles

KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer

Jen Jen Yeh, Elizabeth D. Routh, Tara Rubinas, Janie Peacock, Timothy D. Martin, Xiang Jun Shen, Robert S. Sandler, Hong Jin Kim, Temitope O. Keku, Channing J. Der
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (4): 834–843.
DOI: https://doi.org/10.1158/1535-7163.MCT-08-0972
Published: 16 April 2009
View article
PDF